All Access Articles |
- Axsome Therapeutics Initiates Phase 3 Trial for Binge Eating Disorder Treatment | 2024-04-01 | PHARMACEUTICAL
- Axsome Therapeutics Reveals Survey Results – NT1 Patients Still Experience Symptoms | 2024-03-25 | PHARMACEUTICAL
- Axsome Therapeutics Initiates Phase 3 Trial for MDD Treatment | 2024-03-19 | PHARMACEUTICAL